BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 34807508)

  • 1. 2',3'-Cyclic GMP-AMP Dinucleotides for STING-Mediated Immune Modulation: Principles, Immunotherapeutic Potential, and Synthesis.
    Shang M; Lu K; Guan W; Cao S; Ren M; Zhou C
    ChemMedChem; 2022 Jan; 17(2):e202100671. PubMed ID: 34807508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclic GMP-AMP as an Endogenous Second Messenger in Innate Immune Signaling by Cytosolic DNA.
    Kato K; Omura H; Ishitani R; Nureki O
    Annu Rev Biochem; 2017 Jun; 86():541-566. PubMed ID: 28399655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A STING to inflammation and autoimmunity.
    Kumar V
    J Leukoc Biol; 2019 Jul; 106(1):171-185. PubMed ID: 30990921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The catalytic mechanism of cyclic GMP-AMP synthase (cGAS) and implications for innate immunity and inhibition.
    Hall J; Ralph EC; Shanker S; Wang H; Byrnes LJ; Horst R; Wong J; Brault A; Dumlao D; Smith JF; Dakin LA; Schmitt DC; Trujillo J; Vincent F; Griffor M; Aulabaugh AE
    Protein Sci; 2017 Dec; 26(12):2367-2380. PubMed ID: 28940468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cGAS-STING pathway as a therapeutic target in inflammatory diseases.
    Decout A; Katz JD; Venkatraman S; Ablasser A
    Nat Rev Immunol; 2021 Sep; 21(9):548-569. PubMed ID: 33833439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor Activity of cGAMP via Stimulation of cGAS-cGAMP-STING-IRF3 Mediated Innate Immune Response.
    Li T; Cheng H; Yuan H; Xu Q; Shu C; Zhang Y; Xu P; Tan J; Rui Y; Li P; Tan X
    Sci Rep; 2016 Jan; 6():19049. PubMed ID: 26754564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING.
    Diner EJ; Burdette DL; Wilson SC; Monroe KM; Kellenberger CA; Hyodo M; Hayakawa Y; Hammond MC; Vance RE
    Cell Rep; 2013 May; 3(5):1355-61. PubMed ID: 23707065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second messenger 2'3'-cyclic GMP-AMP (2'3'-cGAMP): the cell autonomous and non-autonomous roles in cancer progression.
    Ma XY; Chen MM; Meng LH
    Acta Pharmacol Sin; 2024 May; 45(5):890-899. PubMed ID: 38177693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The induction of inflammation by the cGAS-STING pathway in human dental pulp cells: A laboratory investigation.
    Tian X; Liu C; Wang Z
    Int Endod J; 2022 Jan; 55(1):54-63. PubMed ID: 34570917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-Derived cGAMP Triggers a STING-Mediated Interferon Response in Non-tumor Cells to Activate the NK Cell Response.
    Marcus A; Mao AJ; Lensink-Vasan M; Wang L; Vance RE; Raulet DH
    Immunity; 2018 Oct; 49(4):754-763.e4. PubMed ID: 30332631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the cGAS-cGAMP-STING Activity of Cancer Cells.
    Pépin G; Gantier MP
    Methods Mol Biol; 2018; 1725():257-266. PubMed ID: 29322423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrinsic strategies for the evasion of cGAS-STING signaling-mediated immune surveillance in human cancer: How therapy can overcome them.
    Zou SS; Qiao Y; Zhu S; Gao B; Yang N; Liu YJ; Chen J
    Pharmacol Res; 2021 Apr; 166():105514. PubMed ID: 33631336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Viral and metazoan poxins are cGAMP-specific nucleases that restrict cGAS-STING signalling.
    Eaglesham JB; Pan Y; Kupper TS; Kranzusch PJ
    Nature; 2019 Feb; 566(7743):259-263. PubMed ID: 30728498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cGAS/STING Pathway: A Novel Target for Cancer Therapy.
    Gan Y; Li X; Han S; Liang Q; Ma X; Rong P; Wang W; Li W
    Front Immunol; 2021; 12():795401. PubMed ID: 35046953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of double-stranded DNA sensing through the cGAS-STING pathway.
    Shu C; Li X; Li P
    Cytokine Growth Factor Rev; 2014 Dec; 25(6):641-8. PubMed ID: 25007740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STING activation in cancer immunotherapy.
    Su T; Zhang Y; Valerie K; Wang XY; Lin S; Zhu G
    Theranostics; 2019; 9(25):7759-7771. PubMed ID: 31695799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms and cellular functions of cGAS-STING signalling.
    Hopfner KP; Hornung V
    Nat Rev Mol Cell Biol; 2020 Sep; 21(9):501-521. PubMed ID: 32424334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cGAS-cGAMP-STING Pathway: A Molecular Link Between Immunity and Metabolism.
    Bai J; Liu F
    Diabetes; 2019 Jun; 68(6):1099-1108. PubMed ID: 31109939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structures and Mechanisms in the cGAS-STING Innate Immunity Pathway.
    Zhang X; Bai XC; Chen ZJ
    Immunity; 2020 Jul; 53(1):43-53. PubMed ID: 32668227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, Synthesis and Biological Evaluation of (2',5' and 3'5'-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING).
    Xie X; Liu J; Wang X
    Molecules; 2020 Nov; 25(22):. PubMed ID: 33198423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.